These findings indicated T-cell infiltration or T cell-inflamed microenvironment in HPV positive HNSCC contributed to the efficacy of anti-PD-1 therapy, whereas HPV-infection itself may not alter the survival of HNSCC patients. This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.